The Motley Fool

Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.

Multiple patent cliffs raise concerns about whether Bristol Myers Squibb can maintain its dividend growth streak. $3.5 billion in anticipated annual cost savings could help the pharmaceutical company ...

Is Bristol Myers Squibb's 4.3% dividend yield safe? Here's what investors need to know.

This big pharma stock looks attractive for income investors -- but it comes with some risk.
Hosted on MSN

How safe is Bristol Myers Squibb's dividend? Here's my honest take.

Bristol Myers Squibb's yield is well above the pharma average, and it has patent expirations on the horizon. The payout ratio isn't outlandishly high, and the company is financially strong, as it ...
AOL

Bristol‑Myers Squibb: The Boring Dividend Stock I'd Happily Hold Through Any Crash

Boring is beautiful. That adage is especially true during turbulent times. If you haven't noticed, the current market and world conditions are quite tumultuous. Let's address what's probably the ...
AOL

Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend?

A big theme for investors in 2026 has been to buy dividend stocks. They can make for valuable investments for not only the recurring income they can generate but also their stability, as they are ...
Nasdaq

Bristol Myers Squibb a Top 25 Dividend Giant With 5.06% Yield (BMY)

Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $17.02B worth of stock held by ETFs, and above-average ''DividendRank'' ...
Seeking Alpha

Bristol-Myers Squibb: A Dividend Gem With Hidden Upside In 2026

Bristol-Myers Squibb is upgraded to Buy as its growth portfolio now offsets legacy declines, validating a bullish contrarian thesis. BMY's 2026 guidance and Q4 2025 results exceeded consensus, with ...
Business Wire

Bristol Myers Squibb Announces Dividend Increase

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-three cents ($0.63) per share on the $0.10 par ...
The Motley Fool

What about Bristol Myers Squibb's patent cliff?

Let's address what's probably the biggest objection about Bristol Myers Squibb -- its patent cliff. The company's two top-selling drugs, blood thinner Eliquis and cancer immunotherapy Opdivo, both ...
Nasdaq

Bristol Myers Squibb a Top 25 Dividend Giant With 4.76% Yield (BMY)

Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $18.88B worth of stock held by ETFs, and above-average ''DividendRank'' statistics ...
Business Wire

Bristol Myers Squibb Announces Dividend

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-three cents ($0.63) per share on the $0.10 par ...